Board of Directors
Our goal is to ensure the progressive advancement of the medical and economic success of our company. To enable our medium-sized family business from Iserlohn to succeed at an international level, we have focussed on strengthening our company management team. We have added two directors with a wealth of experience and competence to assist with our long-term company planning and to make a personal contribution in transforming our visions into reality.
Dr med. Katja Pütter-Ammer
Dr. Katja Pütter-Ammer has been a member of the Board of Managing Directors of MEDICE since 2001.
Katja Pütter-Ammer, MD, has been the company's main shareholder since the death of her father, Dr. Sigurd Pütter, in June 2021 and, together with her husband, Dr. med. Dr. oec. Richard Ammer, is the Executive Chairman of the Management Board.
Since 2001, the two have been managing the family business in the third generation. Today, the MEDICE Group is one of the most successful owner-managed family companies in the German pharmaceutical industry, with more than 1,000 employees and annual sales of over 300 million euro in around 50 markets worldwide.
Dr. Katja Pütter-Ammer was born in 1967 in Iserlohn. She is a medical doctor with a further qualification as Master of Science in Pharmaceutical Medicine.
After her studies, she worked as a doctor at Munich University Hospital and then moved to Boston to do research at Tufts University, where she was also awarded Harvard University's Certificate of Studies in Business and Administration.
To prepare for the takeover of the family business, Dr. Pütter-Ammer joined GlaxoSmithKline in 1998, where she gained additional expertise in clinical research and product management.
Since 2010, Dr. Katja Pütter-Ammer has been a member of the task force "Marke im Pharmamarkt" [Brands in the Pharmaceutical Market].
Dr. Pütter-Ammer also worked for several years as a lecturer at the University of St. Gallen.
Dr med. Dr. oec. Richard Ammer
Dr. med. Dr. oec. Richard Ammer is active as managing owner, as general manager since 2003 responsible for search & development, medical & regulatory affairs, manufacturing, market access and international marketing & distribution.
Dr. Richard Ammer was born in Munich in 1970 and is a graduate in human medicine and business administration.
Following his medical studies in Munich and Boston, and his clinical and scientific training at Harvard Medical School, Massachusetts General Hospital, he pursued his clinical education in internal medicine at the German Heart Center in Munich and at the University Hospital in Münster. He completed his studies in business administration and economics at the University of St. Gallen and Harvard Extension School.
Dr. Ammer won the Young Investigator Award 2001 in Basic Science, awarded by the European Society of Cardiology. He was also the coordinator and director of the nation-wide network of excellence and competence for cardiovascular disorders (atrial fibrillation), and he has worked at University Hospital Münster for 20 years in the Department of Internal Medicine, where he has been responsible both for patient care and academic teaching. He has also been assistant professor at University St. Gallen (CH)for 20 years.
Since 2008, Dr. Richard Ammer has been Assistant Chair of the Board at the Bundesverband der Pharmazeutischen Industrie BPI e.V. [German Pharmaceutical Industry Association].
Eric Neyret has been Director of Finance, Controlling and Administration since 2012.
Eric Neyret was born in Lyon (France) in 1964, where he also graduated in Politics, with a specialism in economics.
After completing his education, he worked for many years in international pharmaceutical companies. In this time, his work focused on establishing regional organisations to increase the international presence of the companies, and on developing the structures necessary in the wake of this company expansion, as well as on commercial projects.
Most recently, as Vice-Chair of Finance & Services – CFO Europe, he directed the Controlling, Finance, IT and Purchasing departments of an international pharmaceutical company.
MEDICE's international expansion and dramatic growth in recent years has required new national and international structures to be set up, and Eric Neyret has been able to accomplish this successfully at MEDICE thanks to his many years of experience.
Dr. Uwe Baumann
Dr. Uwe Baumann has been Managing Director at MEDICE since July 1, 2021 and is responsible for the OTC division. Since August 1, 2021, he has also been Managing Director of Schaper & Brümmer, a company belonging to the MEDICE group.
He was born in Essen in 1959. The microbiologist received his doctorate from the Westphalian Wilhelms University. From 1985 to 1995, Uwe Baumann was active as a local politician for the “Bündnis 90/Die Grünen” party in Münster, including 5 years as parliamentary group chairman in the city council. After some time in university research, Uwe Baumann moved to the pharmaceutical industry in 1993 and held senior positions at Hoffman-La Roche, Novartis and Bionorica before joining MEDICE.
In addition, he taught marketing and strategy at the Cooperative State University in Lörrach.
He is a member of the supervisory board of Scalyst AG, Berngau and Marpinion GmbH, Oberhaching.